你即將離開本站

並前往https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate

For more information on the EPIC Phase 2/3 clinical trials for PAXLOVID™, visit clinicaltrials.gov . About Pfizer's Commitment to Equitable ...

確定！ 回上一頁

查詢 「Clinical trial gov」的人也找了：